Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnostic instrument
|
| gptkbp:automationLevel |
fully automated
|
| gptkbp:detects |
fungal pathogens
bacterial pathogens |
| gptkbp:feature |
multiplexing capability
random access capability direct-from-blood testing no blood culture required |
| https://www.w3.org/2000/01/rdf-schema#label |
T2Dx Instrument
|
| gptkbp:launched |
2014
|
| gptkbp:manufacturer |
gptkb:T2_Biosystems
|
| gptkbp:marketedAs |
gptkb:T2_Biosystems
|
| gptkbp:panelType |
gptkb:T2Bacteria_Panel
gptkb:T2Candida_Panel gptkb:T2Resistance_Panel gptkb:T2SARS-CoV-2_Panel |
| gptkbp:regulates |
gptkb:FDA
gptkb:CE_Mark |
| gptkbp:technology |
gptkb:T2_Magnetic_Resonance_(T2MR)
|
| gptkbp:turnaroundTime |
3-5 hours
|
| gptkbp:type |
whole blood
|
| gptkbp:usedFor |
rapid diagnostic testing
detection of sepsis-causing pathogens |
| gptkbp:usedIn |
clinical laboratories
|
| gptkbp:website |
https://www.t2biosystems.com/products/t2dx-instrument/
|
| gptkbp:bfsParent |
gptkb:T2_Biosystems
|
| gptkbp:bfsLayer |
6
|